The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial
Open accessAbstract
Importance: Adjunctive hydrocortisone therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The efficacy of hydrocortisone in patients with severe sepsis without shock remains controversial. Objective: To determine whether hydrocortisone therapy in patients with severe sepsis prevents the development of septic shock. Design, Setting, and Participants: Double-blind, randomized clinical trial conducted from January 13, 2009, to August 27, 2013, with a follow-up of 180 days until February 23, 2014. The trial was performed in 34 intermediate or intensive care units of university and community hospitals in Germany, and it included 380 adult patients with severe sepsis who were not in septic shock. Interventions: Patients were randomly allocated 1:1 either to receive a continuous infusion of 200 mg of hydrocortisone for 5 days followed by dose tapering until day 11 (n = 190) or to receive placebo (n = 190). Main Outcomes and Measures: The primary outcome was development of septic shock within 14 days. Secondary outcomes were time until septic shock, mortality in the intensive care unit or hospital, survival up to 180 days, and assessment of secondary infections, weaning failure, muscle weakness, and hyperglycemia (blood glucose level >150 mg/dL [to convert to millimoles per liter, multiply by 0.0555]). Results: The intention-to-treat population consisted of 353 patients (64.9% male; mean [SD] age, 65.0 [14.4] years). Septic shock occurred in 36 of 170 patients (21.2%) in the hydrocortisone group and 39 of 170 patients (22.9%) in the placebo group (difference, -1.8%; 95% CI, -10.7% to 7.2%; P = .70). No significant differences were observed between the hydrocortisone and placebo groups for time until septic shock; mortality in the intensive care unit or in the hospital; or mortality at 28 days (15 of 171 patients [8.8%] vs 14 of 170 patients [8.2%], respectively; difference, 0.5%; 95% CI, -5.6% to 6.7%; P = .86), 90 days (34 of 171 patients [19.9%] vs 28 of 168 patients [16.7%]; difference, 3.2%; 95% CI, -5.1% to 11.4%; P = .44), and 180 days (45 of 168 patients [26.8%] vs 37 of 167 patients [22.2%], respectively; difference, 4.6%; 95% CI, -4.6% to 13.7%; P = .32). In the hydrocortisone vs placebo groups, 21.5% vs 16.9% had secondary infections, 8.6% vs 8.5% had weaning failure, 30.7% vs 23.8% had muscle weakness, and 90.9% vs 81.5% had hyperglycemia. Conclusions and Relevance: Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days. These findings do not support the use of hydrocortisone in these patients. Trial Registration: clinicaltrials.gov Identifier: NCT00670254.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Self-citationDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationEly, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Self-citationHydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Self-citationThe natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
Ely, E. W., Truman, B., Shintani, A., Thomason, J. W. W., Wheeler, A. P., Gordon, S., Francis, J., Speroff, T., Gautam, S., Margolin, R., et al. (2003) · JAMA · doi:10.1001/jama.289.22.2983 · Cited by 1,707
Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa051693 · Cited by 1,498
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
Moreno, R. P., Metnitz, P. G. H., Almeida, E., Jordan, B., Bauer, P., Campos, R. A., Iapichino, G., Edbrooke, D., Capuzzo, M., Le Gall, J.-R., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2763-5 · Cited by 1,413
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Self-citationHydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Keh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600 · cited 1×
“Hospital 25 (16-40) 26 (16-46) 26 (16-43) .”
Self-citationTorres, A., Sibila, O., Ferrer, M., Polverino, E., Menendez, R., Mensa, J., Gabarrús, A., Sellarés, J., Restrepo, M. I., Anzueto, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.88 · Cited by 571
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
Self-citationBlum, C. A., Nigro, N., Briel, M., Schuetz, P., Ullmer, E., Suter-Widmer, I., Winzeler, B., Bingisser, R., Elsaesser, H., Drozdov, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62447-8 · Cited by 409
Annane, D., Sebille, V., & Charpentier, C. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00997-2 · Cited by 382
Meijvis, S. C., Hardeman, H., Remmelts, H. H., Heijligenberg, R., Rijkers, G. T., van Velzen-Blad, H., Voorn, G. P., van de Garde, E. M., Endeman, H., Grutters, J. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60607-7 · Cited by 366
Siemieniuk, R. A. C., Meade, M. O., Alonso-Coello, P., Briel, M., Evaniew, N., Prasad, M., Alexander, P. E., Fei, Y., Vandvik, P. O., Loeb, M., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0715 · Cited by 324
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*
Vincent, J.-L., Angus, D. C., Artigas, A., Kalil, A., Basson, B. R., Jamal, H. H., Johnson, G., & Bernard, G. R. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000051515.56179.e1 · Cited by 302
Alberti, C., Brun-Buisson, C., Goodman, S. V., Guidici, D., Granton, J., Moreno, R., Smithies, M., Thomas, O., Artigas, A., & Le Gall, J. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-785oc · Cited by 262
Hydrocortisone Therapy for Patients With Multiple Trauma: The Randomized Controlled HYPOLYTE Study
Roquilly, A. (2011) · JAMA · doi:10.1001/jama.2011.360 · Cited by 216
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock
Cuthbertson, B. H., Sprung, C. L., Annane, D., Chevret, S., Garfield, M., Goodman, S., Laterre, P.-F., Vincent, J. L., Freivogel, K., Reinhart, K., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1603-4 · Cited by 216
Self-citationCorticosteroids for treating sepsis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub3 · Cited by 210
Self-citationPlaschke, K., Fichtenkamm, P., Schramm, C., Hauth, S., Martin, E., Verch, M., Karck, M., & Kopitz, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-2004-4 · Cited by 191
Sligl, W. I., Milner, Jr., Sundar, S., Mphatswe, W., & Majumdar, S. R. (2009) · Clinical Infectious Diseases · doi:10.1086/599343 · Cited by 163
Systemic Steroids in Severe Sepsis and Septic Shock
Patel, G. P., & BALK, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1897ci · Cited by 154
Liu, V. X., Morehouse, J. W., Marelich, G. P., Soule, J., Russell, T., Skeath, M., Adams, C. L., Escobar, G. J., & Whippy, A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1489oc · Cited by 141
Cerejeira, J., Batista, P., Nogueira, V., Vaz‐Serra, A., & Mukaetova‐Ladinska, E. B. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713495449 · Cited by 132
Corticosteroids and Transition to Delirium in Patients With Acute Lung Injury*
Schreiber, M. P., Colantuoni, E., Bienvenu, O. J., Neufeld, K. J., Chen, K., Shanholtz, C. B., Méndez-Téllez, P. A., & Needham, D. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000247 · Cited by 130
Intraoperative Dexamethasone and Delirium After Cardiac Surgery
Sauër, A.-M. C., Slooter, A. J. C., Veldhuijzen, D. S., van Eijk, M. M. J., Devlin, J. W., & van Dijk, D. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000248 · Cited by 111
Loisa, P., Parviainen, I., Tenhunen, J., Hovilehto, S., & Ruokonen, E. (2007) · Critical Care · doi:10.1186/cc5696 · Cited by 95
Kalil, A. C., & Sun, J. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2121-0 · Cited by 61
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Gerlach, H., Gründling, M., Kreymann, G., Kujath, P., Marggraf, G., Mayer, K., Meier‐Hellmann, A., et al. (2006) · Der Internist · doi:10.1007/s00108-006-1595-x · Cited by 60
Self-citationNguyen, D. N., Huyghens, L., Zhang, H., Schiettecatte, J., Smitz, J. E. J., & Vincent, J. (2014) · BioMed Research International · doi:10.1155/2014/712742 · Cited by 48
Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia
Remmelts, H. H. F., Meijvis, S. C. A., Heijligenberg, R., Rijkers, G. T., Oosterheert, J. J., Bos, W. J. W., Endeman, H., Grutters, J. C., Hoepelman, A. I. M., & Biesma, D. H. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.03.008 · Cited by 34
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Gerlach, H., Gründling, M., Kreymann, G., Kujath, P., Marggraf, G., Mayer, K., Meier‐Hellmann, A., et al. (2006) · PubMed · Cited by 26
Self-citationIntraoperative dexamethasone and delirium after cardiac surgery: a randomized clinical trial
Sauër, A.-M. C., Slooter, A. J. C., Veldhuijzen, D. S., van Eijk, M. M. J., & van Dijk, D. (2013) · Critical Care · doi:10.1186/cc12334 · Cited by 13
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationMetlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citationHydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Metadata
- Authors
- Keh, D., Trips, E., Marx, G., Wirtz, S. P., Abduljawwad, E., Bercker, S., Bogatsch, H., Briegel, J., Engel, C., Gerlach, H., Goldmann, A., Kuhn, S.-O., Hüter, L., Meier-Hellmann, A., Nierhaus, A., Kluge, S., Lehmke, J., Loeffler, M., Oppert, M., Resener, K., Schädler, D., Schuerholz, T., Simon, P., Weiler, N., Weyland, A., Reinhart, K., Brunkhorst, F. M., & for the SepNet–Critical Care Trials Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-11-01
- Volume
- 316
- Issue
- 17
- Pages
- 1775
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2528956578
- Cited by
- 277
- References
- 44
- FWCI
- 34.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.